Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chiellini, E.
Right arrow Articles by Solaro, R.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Targeted Administration of Proteic Drugs. I. Preparation of Polymeric Nanoparticles

Emo Chiellini

Elisabetta E. Chiellini

Federica Chiellini

Roberto Solaro

Department of Chemistry and Industrial Chemistry, University of Pisa, via Risorgimento 35, 56126 Pisa, Italy

The formulation of hybrid nanoparticles based on synthetic polymer-protein hybrid matrices for the targeted release of proteic drugs with antiviral activity such as a-interferon was investigated. Human serum albumin, alone, or in combination with myoglobin, and the hemiesters of alternating copolymers of maleic anhydride/alkyl vinyl ethers of oligo(ethylene glycol) were selected as proteic and synthetic components, respectively. Digalactosyl diacyl gycerol, a natural glycolipid selectively recognized by the asialofetuin receptor was used for the active targeting of liver hepatocytes. Nanoparticle suspensions were prepared either by slow solvent evaporation from biphase and triphase emulsions or by controlled coprecipitation. Nanoparticles, 0.1-0.3 gm in diameter, were obtained by the latter method, whereas the former one afforded heterogeneous micro and nanoparticle mixtures. Several techniques were tested to separate the nanoparticle dispersions from the suspending solution. The best results, in terms of a homogeneous distribution of mostly spherical nanoparticles, were obtained by centrifugation in the presence of modified cyclodextrins. After lyophilization of supernatant, the resulting fluffy powder was easily resuspendable in water.

Journal of Bioactive and Compatible Polymers, Vol. 16, No. 6, 441-465 (2001)
DOI: 10.1106/6CFL-4E8A-L7XR-MUF7


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
A.M. Piras, F. Chiellini, E. Chiellini, L. Nikkola, and N. Ashammakhi
New Multicomponent Bioerodible Electrospun Nanofibers for Dual-controlled Drug Release
Journal of Bioactive and Compatible Polymers, September 1, 2008; 23(5): 423 - 443.
[Abstract] [PDF]